ITT analysis highlighted no difference between the two groups in the onset of IgE-mediated egg allergy, confirmed by the oral egg challenge (7% active vs. 10.3% placebo) and in cutaneous sensitization (10.8% vs. 15.1%) at 12 months. This evidence concerns the gene IGHE and egg allergy.